{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:34:32Z","timestamp":1789878872887,"version":"4.0.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100007052","name":"Universit\u00e0 degli Studi di Verona","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007052","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s40266-026-01295-9","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T09:20:21Z","timestamp":1775640021000},"page":"397-424","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescribing Cascades: An Umbrella Review and Updated Systematic Review"],"prefix":"10.1007","volume":"43","author":[{"given":"Massimo","family":"Carollo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Crisafulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maccarrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Paladin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Selleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Forti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco U. S.","family":"Mattace-Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-7296","authenticated-orcid":false,"given":"Gianluca","family":"Trifir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"issue":"4","key":"1295_CR1","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1016\/S2666-7568(24)00007-2","volume":"5","author":"K Nicholson","year":"2024","unstructured":"Nicholson K, Liu W, Fitzpatrick D, et al. Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review. Lancet Healthy Longev. 2024;5(4):e287\u201396. https:\/\/doi.org\/10.1016\/S2666-7568(24)00007-2.","journal-title":"Lancet Healthy Longev"},{"issue":"7","key":"1295_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14740338.2018.1491547","volume":"17","author":"D Formica","year":"2018","unstructured":"Formica D, Sultana J, Cutroneo PM, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018;17(7):681\u201395. https:\/\/doi.org\/10.1080\/14740338.2018.1491547.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"1295_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-023-02679-2","volume":"36","author":"M Carollo","year":"2024","unstructured":"Carollo M, Boccardi V, Crisafulli S, et al. Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium. Aging Clin Exp Res. 2024;36(1):63. https:\/\/doi.org\/10.1007\/s40520-023-02679-2.","journal-title":"Aging Clin Exp Res"},{"issue":"7115","key":"1295_CR4","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","volume":"315","author":"PA Rochon","year":"1997","unstructured":"Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315(7115):1096\u20139. https:\/\/doi.org\/10.1136\/bmj.315.7115.1096.","journal-title":"BMJ"},{"key":"1295_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2025.07.001","author":"K Dalton","year":"2025","unstructured":"Dalton K, Evrard P, Moriarty F, et al. How are prescribing cascades defined in the literature? A scoping review. Res Social Adm Pharm. 2025. https:\/\/doi.org\/10.1016\/j.sapharm.2025.07.001.","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"1295_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jgs.15800","volume":"67","author":"LM McCarthy","year":"2019","unstructured":"McCarthy LM, Visentin JD, Rochon PA. Assessing the scope and appropriateness of prescribing cascades. J Am Geriatr Soc. 2019;67(5):1023\u20136. https:\/\/doi.org\/10.1111\/jgs.15800.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"1295_CR7","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1111\/inm.13034","volume":"31","author":"A Hallyburton","year":"2022","unstructured":"Hallyburton A. Diagnostic overshadowing: an evolutionary concept analysis on the misattribution of physical symptoms to pre-existing psychological illnesses. Int J Ment Health Nurs. 2022;31(6):1360\u201372. https:\/\/doi.org\/10.1111\/inm.13034.","journal-title":"Int J Ment Health Nurs"},{"issue":"7","key":"1295_CR8","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2174\/138920011796504473","volume":"12","author":"G Trifir\u00f2","year":"2011","unstructured":"Trifir\u00f2 G, Spina E. Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems. Curr Drug Metab. 2011;12(7):611\u201320. https:\/\/doi.org\/10.2174\/138920011796504473.","journal-title":"Curr Drug Metab"},{"issue":"2","key":"1295_CR9","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/jgs.19282","volume":"73","author":"PA Rochon","year":"2025","unstructured":"Rochon PA, Li J, O\u2019Mahony D, et al. The impact of age, sex, and gender on polypharmacy and potential prescribing cascades: lessons from five databases. J Am Geriatr Soc. 2025;73(2):520\u201332. https:\/\/doi.org\/10.1111\/jgs.19282.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1295_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.1008","volume":"10","author":"AS Doherty","year":"2022","unstructured":"Doherty AS, Shahid F, Moriarty F, et al. Prescribing cascades in community-dwelling adults: a systematic review. Pharmacol Res Perspect. 2022;10(5):e01008. https:\/\/doi.org\/10.1002\/prp2.1008.","journal-title":"Pharmacol Res Perspect"},{"issue":"6","key":"1295_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s40266-025-01201-9","volume":"42","author":"R Daunt","year":"2025","unstructured":"Daunt R, McGettigan S, Kelly L, Curtin D, O\u2019Mahony D. Detection of potential prescribing cascades in multimorbid older patients hospitalised with acute illness\u2014an observational prospective prevalence study. Drugs Aging. 2025;42(6):535\u201346. https:\/\/doi.org\/10.1007\/s40266-025-01201-9.","journal-title":"Drugs Aging"},{"key":"1295_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-070849","author":"M Gates","year":"2022","unstructured":"Gates M, Gates A, Pieper D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022. https:\/\/doi.org\/10.1136\/bmj-2022-070849.","journal-title":"BMJ"},{"key":"1295_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10. https:\/\/doi.org\/10.1186\/1471-2288-7-10.","journal-title":"BMC Med Res Methodol"},{"key":"1295_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https:\/\/doi.org\/10.1136\/bmj.j4008.","journal-title":"BMJ"},{"key":"1295_CR15","unstructured":"JBI critical appraisal tools | JBI. https:\/\/jbi.global\/critical-appraisal-tools. Accessed 4 Sept 2025."},{"issue":"3","key":"1295_CR16","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","volume":"13","author":"E Aromataris","year":"2015","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132\u201340. https:\/\/doi.org\/10.1097\/XEB.0000000000000055.","journal-title":"Int J Evid Based Healthc"},{"key":"1295_CR17","doi-asserted-by":"crossref","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Umbrella reviews (2020). Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. 9. Umbrella reviews. https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL\/355829653\/9.+Umbrella+reviews. Accessed 1 Apr 2025.","DOI":"10.46658\/JBIMES-24-08"},{"issue":"7","key":"1295_CR18","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1016\/j.sapharm.2021.08.003","volume":"18","author":"EJ Morris","year":"2022","unstructured":"Morris EJ, Hollmann J, Hofer AK, et al. Evaluating the use of prescription sequence symmetry analysis as a pharmacovigilance tool: a scoping review. Res Soc Adm Pharm. 2022;18(7):3079\u201393. https:\/\/doi.org\/10.1016\/j.sapharm.2021.08.003.","journal-title":"Res Soc Adm Pharm"},{"key":"1295_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1147921","volume":"14","author":"Z Chen","year":"2023","unstructured":"Chen Z, Liu Z, Zeng L, Huang L, Zhang L. Research on prescribing cascades: a scoping review. Front Pharmacol. 2023;14:1147921. https:\/\/doi.org\/10.3389\/fphar.2023.1147921.","journal-title":"Front Pharmacol"},{"issue":"12","key":"1295_CR20","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s40266-023-01072-y","volume":"40","author":"O Adrien","year":"2023","unstructured":"Adrien O, Mohammad AK, Hugtenburg JG, et al. Prescribing cascades with recommendations to prevent or reverse them: a systematic review. Drugs Aging. 2023;40(12):1085\u2013100. https:\/\/doi.org\/10.1007\/s40266-023-01072-y.","journal-title":"Drugs Aging"},{"key":"1295_CR21","doi-asserted-by":"publisher","DOI":"10.12688\/hrbopenres.13345.2","volume":"4","author":"A Doherty","year":"2021","unstructured":"Doherty A, Moriarty F, Boland F, et al. Prescribing cascades in community-dwelling adults: protocol for a systematic review. HRB Open Res. 2021;4:72. https:\/\/doi.org\/10.12688\/hrbopenres.13345.2.","journal-title":"HRB Open Res"},{"issue":"1","key":"1295_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/phar.2880","volume":"44","author":"F Shahid","year":"2024","unstructured":"Shahid F, Doherty A, Wallace E, Schmiedl S, Alexander GC, Dreischulte T. Prescribing cascades in ambulatory care: a structured synthesis of evidence. Pharmacotherapy. 2024;44(1):87\u201396. https:\/\/doi.org\/10.1002\/phar.2880.","journal-title":"Pharmacotherapy"},{"issue":"1","key":"1295_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/pds.671","volume":"11","author":"GM Clifford","year":"2002","unstructured":"Clifford GM, Farmer RDT. Drug or symptom-induced depression in men treated with alpha 1-blockers for benign prostatic hyperplasia? A nested case\u2013control study. Pharmacoepidemiol Drug Saf. 2002;11(1):55\u201361. https:\/\/doi.org\/10.1002\/pds.671.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"1295_CR24","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1097\/JU.0000000000001079","volume":"204","author":"TE Dyson","year":"2020","unstructured":"Dyson TE, Cantrell MA, Lund BC. Lack of association between 5\u03b1-reductase inhibitors and depression. J Urol. 2020;204(4):793\u20138. https:\/\/doi.org\/10.1097\/JU.0000000000001079.","journal-title":"J Urol"},{"issue":"12","key":"1295_CR25","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1080\/02770903.2021.2018705","volume":"59","author":"CW Fox","year":"2022","unstructured":"Fox CW, Khaw CL, Gerke AK, Lund BC. Montelukast and neuropsychiatric events\u2014a sequence symmetry analysis. J Asthma. 2022;59(12):2360\u20136. https:\/\/doi.org\/10.1080\/02770903.2021.2018705.","journal-title":"J Asthma"},{"issue":"5","key":"1295_CR26","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/phar.1925","volume":"37","author":"KW Hagberg","year":"2017","unstructured":"Hagberg KW, Divan HA, Nickel JC, Jick SS. Risk of incident antidepressant-treated depression associated with use of 5\u03b1-reductase inhibitors compared with use of \u03b1-blockers in men with benign prostatic hyperplasia: a population-based study using the Clinical Practice Research Datalink. Pharmacotherapy. 2017;37(5):517\u201327. https:\/\/doi.org\/10.1002\/phar.1925.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"1295_CR27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1067\/s0190-9622(03)02087-5","volume":"49","author":"K Hersom","year":"2003","unstructured":"Hersom K, Neary MP, Levaux HP, Klaskala W, Strauss JS. Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis. J Am Acad Dermatol. 2003;49(3):424\u201332. https:\/\/doi.org\/10.1067\/s0190-9622(03)02087-5.","journal-title":"J Am Acad Dermatol"},{"key":"1295_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cmpb.2018.03.021","volume":"161","author":"T Hoang","year":"2018","unstructured":"Hoang T, Liu J, Roughead E, Pratt N, Li J. Supervised signal detection for adverse drug reactions in medication dispensing data. Comput Methods Programs Biomed. 2018;161:25\u201338. https:\/\/doi.org\/10.1016\/j.cmpb.2018.03.021.","journal-title":"Comput Methods Programs Biomed"},{"key":"1295_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0208389","author":"D Idema","year":"2025","unstructured":"Idema D, Wang Y, Biehl M, Horvatovich P, Hak E. Effect estimate comparison between the prescription sequence symmetry analysis (PSSA) and parallel group study designs: a systematic review. PLoS ONE. 2025. https:\/\/doi.org\/10.1371\/journal.pone.0208389.","journal-title":"PLoS ONE"},{"issue":"3","key":"1295_CR30","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/pds.3741","volume":"24","author":"E Kr\u00f6ger","year":"2015","unstructured":"Kr\u00f6ger E, Van Marum R, Souverein P, Carmichael PH, Egberts T. Treatment with rivastigmine or galantamine and risk of urinary incontinence: results from a Dutch database study. Pharmacoepidemiol Drug Saf. 2015;24(3):276\u201385. https:\/\/doi.org\/10.1002\/pds.3741.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1295_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/pds.3903","volume":"25","author":"ECC Lai","year":"2016","unstructured":"Lai ECC, Hsieh CY, Wong MB, et al. Comparative risk of oral ulcerations among antipsychotics users\u2014population-based retrospective cohort study. Pharmacoepidemiol Drug Saf. 2016;25(2):123\u201332. https:\/\/doi.org\/10.1002\/pds.3903.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"1295_CR32","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1111\/dom.13820","volume":"21","author":"IC Lega","year":"2019","unstructured":"Lega IC, Bronskill SE, Campitelli MA, et al. Sodium glucose cotransporter 2 inhibitors and risk of genital mycotic and urinary tract infection: a population-based study of older women and men with diabetes. Diabetes Obes Metab. 2019;21(11):2394\u2013404. https:\/\/doi.org\/10.1111\/dom.13820.","journal-title":"Diabetes Obes Metab"},{"key":"1295_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.589091","volume":"12","author":"XX Li","year":"2021","unstructured":"Li XX, Cheng YC, Zhai S, Yao P, Zhan SY, Shi LW. Risk of liver injury associated with intravenous lipid emulsions: a prescription sequence symmetry analysis. Front Pharmacol. 2021;12:589091. https:\/\/doi.org\/10.3389\/fphar.2021.589091.","journal-title":"Front Pharmacol"},{"issue":"10","key":"1295_CR34","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/pds.5252","volume":"30","author":"LC Lund","year":"2021","unstructured":"Lund LC, H\u00f8jlund M, Henriksen DP, Hallas J, Kristensen KB. Sodium-glucose cotransporter-2 inhibitors and the risk of gout: a Danish population based cohort study and symmetry analysis. Pharmacoepidemiol Drug Saf. 2021;30(10):1391\u20135. https:\/\/doi.org\/10.1002\/pds.5252.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"1295_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/oxfordjournals.qjmed.a068836","volume":"86","author":"T MacDonald","year":"1993","unstructured":"MacDonald T, Beardon P, McGilchrit M, Duncan I, McKendrick A, McDevitt D. The risks of symptomatic vaginal candidiasis after oral antibiotic therapy. QJM Int J Med. 1993;86(7):419\u201324. https:\/\/doi.org\/10.1093\/oxfordjournals.qjmed.a068836.","journal-title":"QJM Int J Med"},{"issue":"7","key":"1295_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107587","volume":"34","author":"A Nakhleh","year":"2020","unstructured":"Nakhleh A, Zloczower M, Gabay L, Shehadeh N. Effects of sodium glucose co-transporter 2 inhibitors on genital infections in female patients with type 2 diabetes mellitus\u2014real world data analysis. J Diabetes Complicat. 2020;34(7):107587. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107587.","journal-title":"J Diabetes Complicat"},{"issue":"10","key":"1295_CR37","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/pds.4052","volume":"25","author":"KB Pouwels","year":"2016","unstructured":"Pouwels KB, Widyakusuma NN, Bos JHJ, Hak E. Association between statins and infections among patients with diabetes: a cohort and prescription sequence symmetry analysis. Pharmacoepidemiol Drug Saf. 2016;25(10):1124\u201330. https:\/\/doi.org\/10.1002\/pds.4052.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"s1","key":"1295_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/pds.3512","volume":"22","author":"K Pouwels","year":"2013","unstructured":"Pouwels K, Kalkman A, Schagen D, Visser S, Hak E. Do SSRIs increase the risk of gastrointestinal adverse effects? Pharmacoepidemiol Drug Saf. 2013;22(s1):127. https:\/\/doi.org\/10.1002\/pds.3512.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1295_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-66","volume":"14","author":"NL Pratt","year":"2014","unstructured":"Pratt NL, Ilom\u00e4ki J, Raymond C, Roughead EE. The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study. BMC Med Res Methodol. 2014;14:66. https:\/\/doi.org\/10.1186\/1471-2288-14-66.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"1295_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/clpt.1994.13","volume":"55","author":"M Monane","year":"1994","unstructured":"Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Choodnovskiy I, Avorn J. Topical glaucoma medications and cardiovascular risk in the elderly. Clin Pharmacol Ther. 1994;55(1):76\u201383. https:\/\/doi.org\/10.1038\/clpt.1994.13.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"1295_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-019-0781-1","volume":"19","author":"AK Preiss","year":"2019","unstructured":"Preiss AK, Roughead EE, Pratt NL. Sequence symmetry analysis graphic adjustment for prescribing trends. BMC Med Res Methodol. 2019;19(1):143. https:\/\/doi.org\/10.1186\/s12874-019-0781-1.","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"1295_CR42","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/00004850-200311000-00004","volume":"18","author":"H Rahimtoola","year":"2003","unstructured":"Rahimtoola H, Buurma H, Tijssen CC, Leufkens HG, Egberts ACG. Incidence and determinants of antidepressant drug use in migraine patients. Int Clin Psychopharmacol. 2003;18(6):331\u20139. https:\/\/doi.org\/10.1097\/00004850-200311000-00004.","journal-title":"Int Clin Psychopharmacol"},{"issue":"7","key":"1295_CR43","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/pds.1250","volume":"15","author":"L Silwer","year":"2006","unstructured":"Silwer L, Petzold M, Hallas J, Lundborg CS. Statins and nonsteroidal anti-inflammatory drugs\u2014An analysis of prescription symmetry. Pharmacoepidemiol Drug Saf. 2006;15(7):510\u20131. https:\/\/doi.org\/10.1002\/pds.1250.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"1295_CR44","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5414\/CP201997","volume":"52","author":"M Takada","year":"2014","unstructured":"Takada M, Fujimoto M, Hosomi K. Difference in risk of gastrointestinal complications between users of enteric-coated and buffered low-dose aspirin. Int J Clin Pharmacol Ther. 2014;52(3):181\u201391. https:\/\/doi.org\/10.5414\/CP201997.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"1","key":"1295_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0457-7","volume":"18","author":"Y Takeuchi","year":"2018","unstructured":"Takeuchi Y, Shinozaki T, Matsuyama Y. A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies. BMC Med Res Methodol. 2018;18(1):1\u201315. https:\/\/doi.org\/10.1186\/s12874-017-0457-7.","journal-title":"BMC Med Res Methodol"},{"issue":"11","key":"1295_CR46","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.2165\/00002018-200629110-00007","volume":"29","author":"EL Thacker","year":"2006","unstructured":"Thacker EL, Schneeweiss S. Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients. Drug Saf. 2006;29(11):1077\u201385. https:\/\/doi.org\/10.2165\/00002018-200629110-00007.","journal-title":"Drug Saf"},{"issue":"5","key":"1295_CR47","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/pds.3417","volume":"22","author":"IA Wahab","year":"2013","unstructured":"Wahab IA, Pratt NL, Wiese MD, Kalisch LM, Roughead EE. The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection. Pharmacoepidemiol Drug Saf. 2013;22(5):496\u2013502. https:\/\/doi.org\/10.1002\/pds.3417.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"1295_CR48","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.70038","volume":"136","author":"A Abdelaziz","year":"2025","unstructured":"Abdelaziz A, Gaber CE, Gupta P, Lee TA. High throughput pharmacovigilance screening for roflumilast adverse effects in real-world settings: a sequence symmetry analysis. Basic Clin Pharmacol Toxicol. 2025;136(5):e70038. https:\/\/doi.org\/10.1111\/bcpt.70038.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"12","key":"1295_CR49","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/ph16121694","volume":"16","author":"A Alghamdi","year":"2023","unstructured":"Alghamdi A, Bijlsma MJ, de Vos S, Schuiling-Veninga CCM, Bos JHJ, Hak E. Association between incidence of prescriptions for Alzheimer\u2019s disease and beta-adrenoceptor antagonists: a prescription sequence symmetry analysis. Pharmaceuticals. 2023;16(12):1694. https:\/\/doi.org\/10.3390\/ph16121694.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"1295_CR50","doi-asserted-by":"publisher","first-page":"11494","DOI":"10.1038\/s41598-025-96103-6","volume":"15","author":"A Funabashi","year":"2025","unstructured":"Funabashi A, Ito H, Maeda M, Hasegawa Y, Tsukioka R, Onda M. Evaluation of dipeptidyl peptidase-4 inhibitor-associated gastrointestinal symptoms using the prescription claims database. Sci Rep. 2025;15(1):11494. https:\/\/doi.org\/10.1038\/s41598-025-96103-6.","journal-title":"Sci Rep"},{"issue":"8","key":"1295_CR51","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaf150","volume":"80","author":"ME Growdon","year":"2025","unstructured":"Growdon ME, Jing B, Deardorff WJ, et al. Loop diuretics and subsequent use of urinary symptom medications in older adults: evaluation of a possible prescribing cascade. J Gerontol A Biol Sci Med Sci. 2025;80(8):glaf150. https:\/\/doi.org\/10.1093\/gerona\/glaf150.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"1295_CR52","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/jgs.18892","volume":"72","author":"ME Growdon","year":"2024","unstructured":"Growdon ME, Jing B, Morris EJ, et al. Which older adults are at highest risk of prescribing cascades? A national study of the gabapentinoid\u2013loop diuretic cascade. J Am Geriatr Soc. 2024;72(6):1728\u201340. https:\/\/doi.org\/10.1111\/jgs.18892.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1295_CR53","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/ijpp\/riaf012","volume":"33","author":"H Ito","year":"2025","unstructured":"Ito H, Hasegawa Y, Maeda M, et al. Evaluation of pregabalin-induced oedema using the adverse event spontaneous reporting database and the prescription claims database. Int J Pharm Pract. 2025;33(3):340\u20136. https:\/\/doi.org\/10.1093\/ijpp\/riaf012.","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"1295_CR54","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40264-023-01374-5","volume":"47","author":"JL Janetzki","year":"2024","unstructured":"Janetzki JL, Sykes MJ, Ward MB, Pratt NL. Chronic obstructive pulmonary disease adverse event signals associated with potential inhibitors of glutathione peroxidase 1: a sequence symmetry analysis. Drug Saf. 2024;47(1):59\u201370. https:\/\/doi.org\/10.1007\/s40264-023-01374-5.","journal-title":"Drug Saf"},{"issue":"5","key":"1295_CR55","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1111\/dom.14982","volume":"25","author":"LC Lund","year":"2023","unstructured":"Lund LC, Jensen PH, Potteg\u00e5rd A, Andersen M, Pratt N, Hallas J. Identifying diabetogenic drugs using real world health care databases: a Danish and Australian symmetry analysis. Diabetes Obes Metab. 2023;25(5):1311\u201320. https:\/\/doi.org\/10.1111\/dom.14982.","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"1295_CR56","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1111\/jgs.19191","volume":"72","author":"AK Mohammad","year":"2024","unstructured":"Mohammad AK, Hugtenburg JG, Vanhommerig JW, van den Bemt PMLA, Denig P, Karapinar-Cark\u0131t F. Identifying and quantifying potentially problematic prescribing cascades in clinical practice: a mixed-methods study. J Am Geriatr Soc. 2024;72(12):3681\u201394. https:\/\/doi.org\/10.1111\/jgs.19191.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"1295_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/pds.70132","volume":"34","author":"AM Ndai","year":"2025","unstructured":"Ndai AM, Smith K, Keshwani S, et al. High-throughput screening for prescribing cascades among real-world angiotensin-converting enzyme inhibitor initiators. Pharmacoepidemiol Drug Saf. 2025;34(3):e70132. https:\/\/doi.org\/10.1002\/pds.70132.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1295_CR58","doi-asserted-by":"publisher","DOI":"10.1101\/2025.03.10.25323711","author":"AM Ndai","year":"2025","unstructured":"Ndai AM, Smith K, Keshwani S, et al. High-Throughput screening for prescribing cascades among real-world angiotensin-II receptor blockers (ARBs) initiators. medRxiv. 2025. https:\/\/doi.org\/10.1101\/2025.03.10.25323711.","journal-title":"medRxiv."},{"issue":"3","key":"1295_CR59","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s40801-024-00446-x","volume":"11","author":"R Omata","year":"2024","unstructured":"Omata R, Asami A, Hara A, Urushihara H. Prescribing cascades of loop diuretics and anti-vertigo drugs following treatment with gabapentinoids and benzodiazepines: prescription sequence symmetry analysis of a large-scale claims database including Japanese older adults. Drugs Real World Outcomes. 2024;11(3):529\u201340. https:\/\/doi.org\/10.1007\/s40801-024-00446-x.","journal-title":"Drugs Real World Outcomes"},{"issue":"7","key":"1295_CR60","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/pds.5607","volume":"32","author":"SM Vouri","year":"2023","unstructured":"Vouri SM, Morris EJ, Walsh M, et al. High-throughput screening for prescribing cascades among real world statin initiators. Pharmacoepidemiol Drug Saf. 2023;32(7):773\u201382. https:\/\/doi.org\/10.1002\/pds.5607.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1295_CR61","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/jgs.18103","volume":"71","author":"GHM Wang","year":"2023","unstructured":"Wang GHM, Morris EJ, Smith SM, Hallas J, Vouri SM. Continued potassium supplementation use following loop diuretic discontinuation in older adults: an evaluation of a prescribing cascade relic. J Am Geriatr Soc. 2023;71(2):505\u201315. https:\/\/doi.org\/10.1111\/jgs.18103.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"1295_CR62","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1111\/bcp.15447","volume":"88","author":"SM Vouri","year":"2022","unstructured":"Vouri SM, Morris EJ, Wang GHM, Bilal A, Hallas J, Henriksen D. Association between gabapentinoids and oedema treated with loop diuretics: a pooled sequence symmetry analysis from the USA and Denmark. Br J Clin Pharmacol. 2022;88(12):5269\u201394. https:\/\/doi.org\/10.1111\/bcp.15447.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1295_CR63","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1007\/s10067-024-06891-x","volume":"43","author":"S Lai","year":"2024","unstructured":"Lai S, Hwang BF, Kuo YH, Liu CS, Liao KF. Risk of gout flare after medication: prescription symmetry sequence analysis. Clin Rheumatol. 2024;43(3):1183\u20138. https:\/\/doi.org\/10.1007\/s10067-024-06891-x.","journal-title":"Clin Rheumatol"},{"key":"1295_CR64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/DHPS.S506523","volume":"17","author":"SG Chikermane","year":"2025","unstructured":"Chikermane SG, Li J, Aparasu RR. Risk of antipsychotic initiation among older dementia patients initiating cholinesterase inhibitors. DHPS. 2025;17:75\u201385. https:\/\/doi.org\/10.2147\/DHPS.S506523.","journal-title":"DHPS"},{"issue":"1","key":"1295_CR65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/ggi.14755","volume":"24","author":"S Hasegawa","year":"2024","unstructured":"Hasegawa S, Mizokami F, Mizuno T, et al. Investigation of geriatric syndromes associated with medication in Japan using insurance claims data. Geriatr Gerontol Int. 2024;24(1):61\u20137. https:\/\/doi.org\/10.1111\/ggi.14755.","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"1295_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-58153-0","volume":"14","author":"SY Lu","year":"2024","unstructured":"Lu SY, Hsu HY, Hsieh YW, Lu CR, Huang HY, Chang SS. Prescribing cascades of antigout medications from thiazide diuretics in gout-na\u00efve hypertensive adults receiving first-line pharmacological management. Sci Rep. 2024;14(1):7402. https:\/\/doi.org\/10.1038\/s41598-024-58153-0.","journal-title":"Sci Rep"},{"key":"1295_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.878092","author":"SC Trenaman","year":"2022","unstructured":"Trenaman SC, Harding A, Bowles SK, Kirkland SA, Andrew MK. A prescribing cascade of proton pump inhibitors following anticholinergic medications in older adults with dementia. Front Pharmacol. 2022. https:\/\/doi.org\/10.3389\/fphar.2022.878092.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1295_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpsy.2022.06.002","volume":"37","author":"P Zagozdzon","year":"2023","unstructured":"Zagozdzon P, Dorozynski P, Waszak P, Harasimowicz A, Dziubich T. Antipsychotic drug prescription sequence analysis in relation to death occurrence and cardiometabolic drug usage: a retrospective longitudinal study. Eur J Psychiatry. 2023;37(1):1\u20137. https:\/\/doi.org\/10.1016\/j.ejpsy.2022.06.002.","journal-title":"Eur J Psychiatry"},{"issue":"5","key":"1295_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22159\/ajpcr.2025v18i5.54320","volume":"18","author":"A Ravinandan","year":"2025","unstructured":"Ravinandan A, Maheswari E, Vishwas HN. Rethinking prescriptions: designing a clinical process map to mitigate dapagliflozin-induced prescribing cascades. Asian J Pharm Clin Res. 2025;18(5):1\u20134. https:\/\/doi.org\/10.22159\/ajpcr.2025v18i5.54320.","journal-title":"Asian J Pharm Clin Res"},{"issue":"2","key":"1295_CR70","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2174\/0115748863288106240313042127","volume":"20","author":"A Dehade","year":"2025","unstructured":"Dehade A, Chakrabarti SS, Reddy NTS, Kaur U. Dopaminergic drugs and valproate-associated refractory hyponatremia over levosulpiride-induced parkinsonism in an elderly female patient when deprescribing was the only therapy. Curr Drug Saf. 2025;20(2):232\u20136. https:\/\/doi.org\/10.2174\/0115748863288106240313042127.","journal-title":"Curr Drug Saf"},{"issue":"3","key":"1295_CR71","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000001685","volume":"31","author":"YY Hsieh","year":"2024","unstructured":"Hsieh YY, Lin CM, Chen CY. Serotonin syndrome from the complex drug interactions of second-generation antipsychotics in older patients: case report and literature review. Am J Ther. 2024;31(3):e300. https:\/\/doi.org\/10.1097\/MJT.0000000000001685.","journal-title":"Am J Ther"},{"issue":"8","key":"1295_CR72","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/ggi.70118","volume":"25","author":"YY Lan","year":"2025","unstructured":"Lan YY, Kovinthapillai R, Szostakiewicz J, Neumann-Podczaska A, Wieczorowska-Tobis K. Less is more: a case of interdisciplinary deprescribing of multiple neuroleptics and polypharmacy in a geriatric patient with neurodegenerative diseases in long-term care. Geriatr Gerontol Int. 2025;25(8):1149\u201351. https:\/\/doi.org\/10.1111\/ggi.70118.","journal-title":"Geriatr Gerontol Int"},{"issue":"1","key":"1295_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010118","volume":"59","author":"J Russell","year":"2023","unstructured":"Russell J, Arwood MJ, Toro-Pag\u00e1n NMD, et al. Case report: performing a medication safety review assisted by pharmacogenomics to explain a prescribing cascade resulting in a patient fall. Med B Aires. 2023;59(1):118. https:\/\/doi.org\/10.3390\/medicina59010118.","journal-title":"Med B Aires"},{"issue":"3","key":"1295_CR74","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s41999-022-00636-2","volume":"13","author":"C Elli","year":"2022","unstructured":"Elli C, Novella A, Nobili A, Ianes A, Pasina L. Anemia in nursing homes, proton pump inhibitors and prescribing cascade of antianemic drugs. Eur Geriatr Med. 2022;13(3):553\u20138. https:\/\/doi.org\/10.1007\/s41999-022-00636-2.","journal-title":"Eur Geriatr Med"},{"issue":"1","key":"1295_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/npr2.12499","volume":"45","author":"S Ochi","year":"2025","unstructured":"Ochi S, Tsuboi T, Hasegawa N, et al. The association between benzodiazepine prescriptions and the risk of laxative use in schizophrenia treatment. Neuropsychopharmacol Rep. 2025;45(1):e12499. https:\/\/doi.org\/10.1002\/npr2.12499.","journal-title":"Neuropsychopharmacol Rep"},{"issue":"5","key":"1295_CR76","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11883","volume":"5","author":"MT Rahbek","year":"2022","unstructured":"Rahbek MT, Gram EAB, Hallas J, Christensen MMH, Lund LC. Analysis of antiemetic use after initiation of hormone therapy. JAMA Netw Open. 2022;5(5):e2211883. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.11883.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1295_CR77","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1159\/000531240","volume":"52","author":"Y Saito","year":"2023","unstructured":"Saito Y, Oishi S, Takizawa T, et al. Analysis of concomitant medications prescribed with antipsychotics to patients with dementia. Dement Geriatr Cogn Disord. 2023;52(4):222\u201331. https:\/\/doi.org\/10.1159\/000531240.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"8","key":"1295_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272418","volume":"17","author":"B Farrell","year":"2022","unstructured":"Farrell B, Galley E, Jeffs L, Howell P, McCarthy LM. \u201cKind of blurry\u201d: deciphering clues to prevent, investigate and manage prescribing cascades. PLoS\u00a0One. 2022;17(8):e0272418. https:\/\/doi.org\/10.1371\/journal.pone.0272418.","journal-title":"PLoS\u00a0One"},{"issue":"10","key":"1295_CR79","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40266-022-00964-9","volume":"39","author":"LM McCarthy","year":"2022","unstructured":"McCarthy LM, Savage R, Dalton K, et al. ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people. Drugs Aging. 2022;39(10):829\u201340. https:\/\/doi.org\/10.1007\/s40266-022-00964-9.","journal-title":"Drugs Aging"},{"key":"1295_CR80","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-025-01215-x","author":"PA Rochon","year":"2025","unstructured":"Rochon PA, O\u2019Mahony D, Cherubini A, et al. International expert panel\u2019s potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med. 2025. https:\/\/doi.org\/10.1007\/s41999-025-01215-x.","journal-title":"Eur Geriatr Med"},{"key":"1295_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2024.105629","volume":"128","author":"SG Chikermane","year":"2025","unstructured":"Chikermane SG, Li J, Aparasu RR. Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer\u2019s disease. Arch Gerontol Geriatr. 2025;128:105629. https:\/\/doi.org\/10.1016\/j.archger.2024.105629.","journal-title":"Arch Gerontol Geriatr"},{"issue":"11","key":"1295_CR82","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/jgs.15543","volume":"66","author":"H Brath","year":"2018","unstructured":"Brath H, Mehta N, Savage RD, et al. What is known about preventing, detecting, and reversing prescribing cascades: a scoping review. J Am Geriatr Soc. 2018;66(11):2079\u201385. https:\/\/doi.org\/10.1111\/jgs.15543.","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"1295_CR83","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac138","volume":"51","author":"D O\u2019Mahony","year":"2022","unstructured":"O\u2019Mahony D, Rochon PA. Prescribing cascades: we see only what we look for, we look for only what we know. Age Ageing. 2022;51(7):afac138. https:\/\/doi.org\/10.1093\/ageing\/afac138.","journal-title":"Age Ageing"},{"issue":"7","key":"1295_CR84","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1097\/HJH.0b013e3283472643","volume":"29","author":"H Makani","year":"2011","unstructured":"Makani H, Bangalore S, Romero J, et al. Peripheral edema associated with calcium channel blockers: incidence and withdrawal rate--a meta-analysis of randomized trials. J Hypertens. 2011;29(7):1270\u201380. https:\/\/doi.org\/10.1097\/HJH.0b013e3283472643.","journal-title":"J Hypertens"},{"issue":"5","key":"1295_CR85","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.japh.2018.06.014","volume":"58","author":"SM Vouri","year":"2018","unstructured":"Vouri SM, van Tuyl JS, Olsen MA, Xian H, Schootman M. An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade. J Am Pharm Assoc (2003). 2018;58(5):534-539.e4. https:\/\/doi.org\/10.1016\/j.japh.2018.06.014.","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"5","key":"1295_CR86","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/rheumatology\/kew293","volume":"56","author":"C Ben Salem","year":"2017","unstructured":"Ben Salem C, Slim R, Fathallah N, Hmouda H. Drug-induced hyperuricaemia and gout. Rheumatology (Oxford). 2017;56(5):679\u201388. https:\/\/doi.org\/10.1093\/rheumatology\/kew293.","journal-title":"Rheumatology (Oxford)"},{"issue":"18","key":"1295_CR87","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.2174\/1381612043384123","volume":"10","author":"K Burgyone","year":"2004","unstructured":"Burgyone K, Aduri K, Ananth J, Parameswaran S. The use of antiparkinsonian agents in the management of drug-induced extrapyramidal symptoms. Curr Pharm Des. 2004;10(18):2239\u201348. https:\/\/doi.org\/10.2174\/1381612043384123.","journal-title":"Curr Pharm Des"},{"issue":"7","key":"1295_CR88","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/archinte.165.7.808","volume":"165","author":"SS Gill","year":"2005","unstructured":"Gill SS, Mamdani M, Naglie G, et al. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med. 2005;165(7):808\u201313. https:\/\/doi.org\/10.1001\/archinte.165.7.808.","journal-title":"Arch Intern Med"},{"issue":"7","key":"1295_CR89","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1111\/jgs.14220","volume":"64","author":"P Lampela","year":"2016","unstructured":"Lampela P, Taipale H, Hartikainen S. Use of cholinesterase inhibitors increases initiation of urinary anticholinergics in persons with Alzheimer\u2019s disease. J Am Geriatr Soc. 2016;64(7):1510\u20132. https:\/\/doi.org\/10.1111\/jgs.14220.","journal-title":"J Am Geriatr Soc"},{"issue":"10081","key":"1295_CR90","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(17)31188-1","volume":"389","author":"PA Rochon","year":"2017","unstructured":"Rochon PA, Gurwitz JH. The prescribing cascade revisited. Lancet. 2017;389(10081):1778\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(17)31188-1.","journal-title":"Lancet"},{"issue":"3","key":"1295_CR91","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/jcpt.12511","volume":"42","author":"SM Vouri","year":"2017","unstructured":"Vouri SM, Chung JM, Binder EF. Successful intervention to mitigate an acetylcholinesterase inhibitor-induced rhinorrhea prescribing cascade: a case report. J Clin Pharm Ther. 2017;42(3):370\u20131. https:\/\/doi.org\/10.1111\/jcpt.12511.","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"1295_CR92","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1715163516640811","volume":"149","author":"PVQ Nguyen","year":"2016","unstructured":"Nguyen PVQ, Spinelli C. Prescribing cascade in an elderly woman. Can Pharm J\/Rev Pharm Can. 2016;149(3):122\u20134. https:\/\/doi.org\/10.1177\/1715163516640811.","journal-title":"Can Pharm J\/Rev Pharm Can"},{"issue":"6","key":"1295_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2329-6887.1000152","volume":"2","author":"FZ Ribo","year":"2014","unstructured":"Ribo FZ, Ribo A. Ertapenem-induced neuropsychiatric symptoms in an elderly patient with chronic kidney disease resulting to a prescribing cascade. J Pharmacovigil. 2014;2(6):1\u20133. https:\/\/doi.org\/10.4172\/2329-6887.1000152.","journal-title":"J Pharmacovigil"},{"issue":"1","key":"1295_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-015-1206-1","volume":"4","author":"TS Veloso","year":"2015","unstructured":"Veloso TS, Camb\u00e3o MS. Migraine treatment: a chain of adverse effects. Springerplus. 2015;4(1):409. https:\/\/doi.org\/10.1186\/s40064-015-1206-1.","journal-title":"Springerplus"},{"issue":"1","key":"1295_CR95","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4103\/jgmh.jgmh_17_17","volume":"5","author":"PA Pepa","year":"2018","unstructured":"Pepa PA, Langley-DeGroot MH, Rule OS. Prescribing cascade in a geropsychiatric patient: a slippery slope. J Geriatr Ment Health. 2018;5(1):62. https:\/\/doi.org\/10.4103\/jgmh.jgmh_17_17.","journal-title":"J Geriatr Ment Health"},{"issue":"2","key":"1295_CR96","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/pnp.665","volume":"24","author":"A Hofmann","year":"2020","unstructured":"Hofmann A, Khalid A, Mao YH, et al. Prescribing cascade in mental health: the older person at risk. Prog Neurol Psychiatry. 2020;24(2):17\u201320. https:\/\/doi.org\/10.1002\/pnp.665.","journal-title":"Prog Neurol Psychiatry"},{"issue":"6","key":"1295_CR97","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15506","volume":"13","author":"AF Becerra","year":"2021","unstructured":"Becerra AF, Boch M, Al-Mezrakchi YA. Ropinirole-associated orthostatic hypotension as cause of a prescribing cascade in an elderly man. Cureus. 2021;13(6):e15506. https:\/\/doi.org\/10.7759\/cureus.15506.","journal-title":"Cureus"},{"issue":"6","key":"1295_CR98","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1715163513504529","volume":"146","author":"B Farrell","year":"2013","unstructured":"Farrell B, Shamji S, Ingar N. Reducing fall risk while managing pain and insomnia. Can Pharm J (Ott). 2013;146(6):335\u201341. https:\/\/doi.org\/10.1177\/1715163513504529.","journal-title":"Can Pharm J (Ott)"},{"key":"1295_CR99","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3969\/j.issn.1672-3384.2020.05.018","volume":"18","author":"X Yan","year":"2020","unstructured":"Yan X, Chen W, Wang L. Elevated sera creatinine levels in elderly patients caused by prescribing cascade. Clin Medicat J. 2020;18:87\u20139. https:\/\/doi.org\/10.3969\/j.issn.1672-3384.2020.05.018.","journal-title":"Clin Medicat J"},{"issue":"5","key":"1295_CR100","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/14740338.2023.2219892","volume":"22","author":"S Crisafulli","year":"2023","unstructured":"Crisafulli S, Khan Z, Karatas Y, Tuccori M, Trifir\u00f2 G. An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting. Expert Opin Drug Saf. 2023;22(5):373\u201380. https:\/\/doi.org\/10.1080\/14740338.2023.2219892.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"1295_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01296-8","volume":"9","author":"MS Brueckle","year":"2020","unstructured":"Brueckle MS, Thomas ET, Seide SE, et al. Adverse drug reactions associated with amitriptyline\u2014protocol for a systematic multiple-indication review and meta-analysis. Syst Rev. 2020;9(1):59. https:\/\/doi.org\/10.1186\/s13643-020-01296-8.","journal-title":"Syst Rev"},{"issue":"7","key":"1295_CR102","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-017-0281-8","volume":"32","author":"ECC Lai","year":"2017","unstructured":"Lai ECC, Pratt N, Hsieh CY, et al. Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies. Eur J Epidemiol. 2017;32(7):567\u201382. https:\/\/doi.org\/10.1007\/s10654-017-0281-8.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"1295_CR103","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.1736","volume":"18","author":"I Tsiropoulos","year":"2009","unstructured":"Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf. 2009;18(6):483\u201391. https:\/\/doi.org\/10.1002\/pds.1736.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"1295_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089795","volume":"9","author":"ECC Lai","year":"2014","unstructured":"Lai ECC, Hsieh CY, Kao Yang YH, Lin SJ. Detecting potential adverse reactions of sulpiride in schizophrenic patients by prescription sequence symmetry analysis. PLoS\u00a0One. 2014;9(2):e89795. https:\/\/doi.org\/10.1371\/journal.pone.0089795.","journal-title":"PLoS\u00a0One"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01295-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01295-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01295-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T10:48:39Z","timestamp":1778064519000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01295-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1295"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01295-9","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GT has served, over the last 3 years, on advisory boards\/seminars funded by Sanofi, MSD, Alfa Sigma, Eli Lilly, Celgene, Daiichi Sankyo, Novo Nordisk, Gilead, and Amgen on topics not related to content of this paper; he is also a scientific coordinator of the academic spin-off \u201cINSPIRE srl,\u201d which has received funding in the last three years from several pharmaceutical companies (Kiowa Kirin, Shionogi, Shire, Novo Nordisk, and Daiichi Sankyo) for conducting observational studies and additional consultancy services on topics not related to the content of this paper. Additionally, he serves as a consultant for Viatris in a legal case related to an adverse reaction to sertraline. None of these listed activities is related to the topic of the article. The other authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All supporting data are contained within the main text and supplementary materials.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"GT supervised the study and conceived the concept. MC, SC, MZ, FM, AP, MS, and AF conducted the first phases of the review (i.e., preliminary searches, study selection process, formal screening of search results against eligibility criteria, data extraction, and risk-of-bias assessment). MC wrote the first draft of the manuscript. SC, FMR, and GT critically revised the manuscript. All authors made important intellectual contributions and approved the manuscript for submission. The corresponding author (GT) attests that all listed authors meet authorship criteria and that no others meeting the criteria have been omitted.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}